title: The subcontinental surge.
abstract: Biotech is following big pharma to India, where R&D costs are a fraction of those in the U.S. India itself is working hard to make it happen. Ultimately, this could reduce the price of biotech therapies. But what about India's reputation for disregarding intellectual property rights?
authors: John
authors: J
authors: Carroll